- Home
- TNXP vs SKIN Comparison
TNXP vs SKIN Comparison
Compare TNXP & SKIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNXP
- SKIN
- Stock Information
- Founded
- TNXP 2007
- SKIN 1997
- Country
- TNXP United States
- SKIN United States
- Employees
- TNXP N/A
- SKIN N/A
- Industry
- TNXP Biotechnology: Pharmaceutical Preparations
- SKIN Package Goods/Cosmetics
- Sector
- TNXP Health Care
- SKIN Consumer Discretionary
- Exchange
- TNXP Nasdaq
- SKIN Nasdaq
- Market Cap
- TNXP 197.9M
- SKIN 176.3M
- IPO Year
- TNXP N/A
- SKIN N/A
- Fundamental
- Price
- TNXP $15.12
- SKIN $1.47
- Analyst Decision
- TNXP Buy
- SKIN Buy
- Analyst Count
- TNXP 1
- SKIN 3
- Target Price
- TNXP $70.00
- SKIN $2.42
- AVG Volume (30 Days)
- TNXP 778.7K
- SKIN 1.0M
- Earning Date
- TNXP 11-10-2025
- SKIN 11-06-2025
- Dividend Yield
- TNXP N/A
- SKIN N/A
- EPS Growth
- TNXP N/A
- SKIN N/A
- EPS
- TNXP N/A
- SKIN N/A
- Revenue
- TNXP $10,299,000.00
- SKIN $301,917,000.00
- Revenue This Year
- TNXP $14.79
- SKIN N/A
- Revenue Next Year
- TNXP $933.49
- SKIN $5.61
- P/E Ratio
- TNXP N/A
- SKIN N/A
- Revenue Growth
- TNXP N/A
- SKIN N/A
- 52 Week Low
- TNXP $6.76
- SKIN $0.78
- 52 Week High
- TNXP $130.00
- SKIN $2.69
- Technical
- Relative Strength Index (RSI)
- TNXP 35.51
- SKIN 53.81
- Support Level
- TNXP $13.70
- SKIN $1.24
- Resistance Level
- TNXP $18.25
- SKIN $1.35
- Average True Range (ATR)
- TNXP 1.28
- SKIN 0.11
- MACD
- TNXP 0.07
- SKIN 0.03
- Stochastic Oscillator
- TNXP 26.08
- SKIN 42.57
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
About SKIN The Beauty Health Company
The Beauty Health Co is a category-creating beauty health company that along with its subsidiaries designs, develops, manufactures, markets and sells esthetic technologies and products. The company's brand portfolio includes Hydrafacial, SkinStylus, and Keravive, offering Syndeo device, SkinStylus SteriLock Microsystem, Keravive Peptide Solution and other products.